135 related articles for article (PubMed ID: 30239648)
1. A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.
Pereira MS; Maia L; Azevedo LF; Campos S; Carvalho S; Dias AM; Albergaria A; Lima J; Marcos-Pinto R; Lago P; Pinho SS
J Crohns Colitis; 2019 Jan; 13(1):39-49. PubMed ID: 30239648
[TBL] [Abstract][Full Text] [Related]
2. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission.
Wakai M; Hayashi R; Tanaka S; Naito T; Kumada J; Nomura M; Takigawa H; Oka S; Ueno Y; Ito M; Chayama K
BMC Gastroenterol; 2020 Apr; 20(1):85. PubMed ID: 32245401
[TBL] [Abstract][Full Text] [Related]
4. Parameters of a severe disease course in ulcerative colitis.
Stallmach A; Nickel L; Lehmann T; Bokemeyer B; Bürger M; Hüppe D; Kruis W; Nikolaus S; Preiss JC; Sturm A; Teich N; Schmidt C
World J Gastroenterol; 2014 Sep; 20(35):12574-80. PubMed ID: 25253960
[TBL] [Abstract][Full Text] [Related]
5. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
6. CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis.
Gibson DJ; Hartery K; Doherty J; Nolan J; Keegan D; Byrne K; Martin ST; Buckley M; Sheridan J; Horgan G; Mulcahy HE; Cullen G; Doherty GA
J Clin Gastroenterol; 2018 Jul; 52(6):e48-e52. PubMed ID: 28737646
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.
Román J; Planell N; Lozano JJ; Aceituno M; Esteller M; Pontes C; Balsa D; Merlos M; Panés J; Salas A
Inflamm Bowel Dis; 2013 Feb; 19(2):221-9. PubMed ID: 22605655
[TBL] [Abstract][Full Text] [Related]
8. Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine.
Fukuda T; Naganuma M; Takabayashi K; Hagihara Y; Tanemoto S; Nomura E; Yoshimatsu Y; Sugimoto S; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Mutaguchi M; Inoue N; Ogata H; Iwao Y; Abe T; Kanai T
J Gastroenterol Hepatol; 2020 Nov; 35(11):1878-1885. PubMed ID: 32250471
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
Park SK; Ye BD; Yang SK; Kim SO; Kim J; Kim JW; Park SH; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
J Crohns Colitis; 2014 Oct; 8(10):1254-60. PubMed ID: 24662395
[TBL] [Abstract][Full Text] [Related]
10. Standard treatment of ulcerative colitis.
Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis.
Arai Y; Arihiro S; Matsuura T; Kato T; Matsuoka M; Saruta M; Mitsunaga M; Matsuura M; Fujiwara M; Okayasu I; Ito S; Tajiri H
Inflamm Bowel Dis; 2014 Jul; 20(7):1208-16. PubMed ID: 24846719
[TBL] [Abstract][Full Text] [Related]
12. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
[TBL] [Abstract][Full Text] [Related]
13. Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.
Leoncini G; Villanacci V; Marin MG; Crisafulli V; Cadei M; Antonelli E; Leoci C; Bassotti G
Tech Coloproctol; 2018 Dec; 22(12):941-946. PubMed ID: 30535522
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
15. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
[TBL] [Abstract][Full Text] [Related]
16. Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
Miyahara K; Nouso K; Saito S; Hiraoka S; Harada K; Takahashi S; Morimoto Y; Kobayashi S; Ikeda F; Miyake Y; Shiraha H; Takaki A; Okada H; Amano M; Hirose K; Nishimura S; Yamamoto K
PLoS One; 2013; 8(10):e74861. PubMed ID: 24116015
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.
Iwasa R; Yamada A; Sono K; Furukawa R; Takeuchi K; Suzuki Y
BMC Gastroenterol; 2015 Aug; 15():103. PubMed ID: 26271624
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
[TBL] [Abstract][Full Text] [Related]
19. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
Bello C; Belaiche J; Louis E; Reenaers C
J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
[TBL] [Abstract][Full Text] [Related]
20. Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
Balram B; Joshi H; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Baumgart DC; Peerani F
Dig Dis Sci; 2021 Nov; 66(11):3985-3992. PubMed ID: 33184796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
